TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Lifeline Pharma AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
12,422
|
12,784
|
22,883 |
| Financial expenses |
544
|
345
|
268 |
| Earnings before taxes |
-925
|
561
|
-1,840 |
| Total assets |
11,225
|
9,036
|
10,919 |
| Current assets |
10,805
|
8,641
|
10,538 |
| Current liabilities |
3,747
|
6,264
|
10,620 |
| Equity capital |
-1,097
|
-184
|
-1,022 |
| - share capital |
66
|
71
|
75 |
| Employees (average) |
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-9.8%
|
-2.0%
|
-9.4% |
| Turnover per employee |
4,261
|
7,628 | |
| Profit as a percentage of turnover |
-7.4%
|
4.4%
|
-8.0% |
| Return on assets (ROA) |
-3.4%
|
10.0%
|
-14.4% |
| Current ratio |
288.4%
|
137.9%
|
99.2% |
| Return on equity (ROE) |
84.3%
|
-304.9%
|
180.0% |
| Change turnover |
424
|
-8,897
|
-4,017 |
| Change turnover % |
4%
|
-41%
|
-15% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.